Teladoc Health has experienced a dramatic decline from its previous status as a market favorite, dropping approximately 98% from its peak in February 2021. Initially buoyed by a surge in telehealth usage during the COVID-19 pandemic, the company now confronts significant challenges that have severely impacted investor sentiment.
In the latest earnings call, CEO Charles Divita characterized 2025 as a “repositioning year” for the company, emphasizing the need to implement product changes and enhance the value proposition of their offerings. A primary focus of this effort will be to address notable weaknesses in its online therapy division, BetterHelp, which has been a considerable drag on overall performance.
In the third quarter of 2025, Teladoc reported a revenue decline of 2% year-over-year, totaling approximately $626 million. The performance breakdown revealed mixed results: while integrated care revenue, which represents Teladoc’s virtual healthcare services, increased by 2% to about $390 million, revenue from BetterHelp plummeted by 8% to around $237 million.
Despite these setbacks, some encouraging metrics have emerged from Teladoc’s integrated care segment. Membership in U.S. integrated care grew to 102.5 million, a 9% increase compared to the previous year. Additionally, the chronic care program reported an enrollment of 1.17 million, showing a 4% sequential rise although it reflected a 1% decline year-over-year.
Management is actively working on pivoting BetterHelp to a model that accepts insurance payments instead of primarily relying on cash-paying customers. This strategy aims to enhance the service’s sustainability in the competitive market. While Teladoc’s CFO, Mala Murthy, highlighted that key indicators for BetterHelp, such as conversion rates and user growth, are beginning to align with their expectations, the service continues to face challenges, particularly in its direct-to-consumer cash-pay segment.
Competing services with robust insurance offerings have intensified pressure on BetterHelp, validating the company’s pivot strategy but also highlighting the current weaknesses. The service’s adjusted earnings before interest, taxes, depreciation, and amortization (EBITDA) margin stood at just 1.6% in the third quarter, with a 4% year-over-year decline in average paying users, dropping to 382,000.
Current market conditions have driven Teladoc’s share price down to around $7, translating to a price-to-sales ratio of 0.5. This may appear attractive at first glance, especially alongside the company’s positive cash flow situation, which showed $67.9 million in free cash flow for the third quarter, along with $726 million in cash reserves.
Looking ahead, management projects an annual free cash flow between $170 million and $185 million for 2025. However, the income statement still reveals significant struggles, with a net loss of $49.5 million reported for the third quarter, which includes a non-cash goodwill impairment charge of $12.6 million. Even after accounting for this charge, the company’s adjusted loss remains greater than the $33.3 million net loss from the same quarter the previous year.
Guidance for the upcoming quarter appears weak as well, with revenue projections between $622 million and $652 million, compared to approximately $640 million a year prior. Additionally, expected net losses per share range from $0.25 to $0.10.
Despite the potentially appealing low stock price, the underlying business challenges raise questions about the company’s ability to develop a sustainable model for shareholder value. Given these factors, a cautious approach may be warranted for potential investors considering Teladoc at this juncture.
